GE HealthCare
GE HealthCare, a subsidiary of General Electric, is a leading player in the global healthcare industry, headquartered in the United States. Founded in 1892, the company has evolved significantly, marking key milestones such as the introduction of advanced imaging technologies and innovative patient monitoring systems. With a strong presence in North America, Europe, and Asia, GE HealthCare focuses on medical imaging, monitoring, biomanufacturing, and digital solutions. Its core products, including MRI machines, ultrasound systems, and healthcare IT solutions, are renowned for their cutting-edge technology and reliability. As a pioneer in healthcare innovation, GE HealthCare has consistently maintained a strong market position, recognised for its commitment to improving patient outcomes and operational efficiency in healthcare settings worldwide.
DitchCarbon Score
How does GE HealthCare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GE HealthCare's score of 68 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GE HealthCare's reported carbon emissions
In 2023, GE HealthCare reported total carbon emissions of approximately 246,475,000 kg CO2e. This includes 114 kg CO2e from Scope 1 emissions, 139,701,000 kg CO2e from Scope 2 emissions, and 6,800 kg CO2e from Scope 3 emissions. The company has set ambitious climate commitments, aiming to achieve net zero emissions by 2050. To reach this goal, GE HealthCare has established interim targets: a 42% reduction in operational greenhouse gas emissions (Scope 1 and 2) by 2030, based on a 2022 baseline, and a 25% reduction in Scope 3 emissions from purchased goods and services, upstream transportation and distribution, business travel, and the use of sold products by the same year. Additionally, they aim to reduce emissions at their largest chemical manufacturing site in Uppsala, Sweden, by 30% by 2030. These commitments align with the Science Based Targets initiative (SBTi), which classifies their near-term targets as consistent with limiting global warming to 1.5°C. GE HealthCare's long-term goal includes a 90% reduction in absolute Scope 1, 2, and 3 emissions by 2050 from a 2022 baseline.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 1,670,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000 | 000 |
| Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000 | 000 |
| Scope 3 | 2,790,000,000 | 0,000,000,000 | - | - | - | 0,000 | 0,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GE HealthCare is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
